EYPT Institutional Ownership & Shareholders
EYEPOINT PHARMACEUTICALS INC (EYPT) is currently held by 177 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $1.23B based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026.
Suvretta Capital Management, Llc is currently the largest disclosed institutional shareholder of EYPT tracked by InsiderSet, reporting ownership valued at approximately $118.64M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $2.89M, representing an estimated loss of -97.56% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 58% of the total disclosed EYPT value among the investors covered in this analysis. Major shareholders include Suvretta Capital Management, Llc, Blackrock, Inc., Cormorant Asset Management, Lp, and several other long-term asset managers with concentrated positions in EYEPOINT PHARMACEUTICALS INC (EYPT).
This page ranks the largest institutional EYPT shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
177
Total Reported Value
$1.23B
Largest Holder
Suvretta Capital Management, Llc
Largest Position
$118.64M
Insider Transactions (90d)
3
Latest Filing Quarter
Q2 2026
New Institutional Positions
66
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Suvretta Capital Management, Llc | 2.49% | 8,296,375 | $118,638,163 | $2,890,457 | -$115,747,706 | -97.56% | |
| Blackrock, Inc. | 0.00% | 7,463,197 | $106,723,718 | $2,600,178 | -$104,123,540 | -97.56% | |
| Cormorant Asset Management, Lp | 5.13% | 7,000,000 | $100,100,000 | $2,438,800 | -$97,661,200 | -97.56% | |
| Federated Hermes, Inc. | 0.12% | 5,681,052 | $81,239,044 | $1,979,279 | -$79,259,765 | -97.56% | |
| Adage Capital Partners Gp, L.L.C. | 0.10% | 4,827,792 | $69,037,426 | $1,682,003 | -$67,355,423 | -97.56% | |
| Commodore Capital Lp | 3.92% | 4,600,000 | $65,780,000 | $1,602,640 | -$64,177,360 | -97.56% | |
| Vanguard Capital Management Llc | 0.00% | 3,630,252 | $51,912,604 | $1,264,780 | -$50,647,824 | -97.56% | |
| Janus Henderson Group Plc | 0.02% | 3,601,168 | $46,419,056 | $1,254,647 | -$45,164,409 | -97.30% | |
| Paradigm Biocapital Advisors Lp | 0.77% | 2,890,397 | $41,332,677 | $1,007,014 | -$40,325,663 | -97.56% | |
| State Street Corp | 0.00% | 2,357,545 | $33,712,894 | $821,369 | -$32,891,525 | -97.56% | |
| Geode Capital Management, Llc | 0.00% | 2,062,390 | $29,497,382 | $718,537 | -$28,778,845 | -97.56% | |
| Aberdeen Group Plc | 0.04% | 2,008,802 | $28,725,869 | $699,867 | -$28,026,002 | -97.56% | |
| Citadel Advisors Llc | 0.02% | 1,977,610 | $28,279,823 | $688,999 | -$27,590,824 | -97.56% | |
| Balyasny Asset Management L.P. | 0.05% | 1,812,358 | $25,916,719 | $631,426 | -$25,285,293 | -97.56% | |
| Parkman Healthcare Partners Llc | 1.89% | 1,288,163 | $18,420,731 | $448,796 | -$17,971,935 | -97.56% | |
| Eventide Asset Management, Llc | 0.24% | 1,245,583 | $17,811,837 | $433,961 | -$17,377,876 | -97.56% | |
| Two Sigma Investments, Lp | 0.01% | 1,181,143 | $16,890,345 | $411,510 | -$16,478,835 | -97.56% | |
| Essex Woodlands Management, Inc. | 6.10% | 1,084,857 | $15,513,455 | $377,964 | -$15,135,491 | -97.56% | |
| Orbimed Advisors Llc | 0.29% | 1,069,147 | $15,288,802 | $372,491 | -$14,916,311 | -97.56% | |
| 5Am Venture Management, Llc | 5.22% | 1,050,000 | $15,015,000 | $365,820 | -$14,649,180 | -97.56% | |
| Rosalind Advisors, Inc. | 5.31% | 988,230 | $14,131,689 | $344,299 | -$13,787,390 | -97.56% | |
| Vanguard Portfolio Management Llc | 0.00% | 971,014 | $13,885,500 | $338,301 | -$13,547,199 | -97.56% | |
| Ameriprise Financial Inc | 0.00% | 848,410 | $12,132,298 | $295,586 | -$11,836,712 | -97.56% | |
| Dimensional Fund Advisors Lp | 0.00% | 841,746 | $12,035,896 | $293,264 | -$11,742,632 | -97.56% | |
| Hsbc Holdings Plc | 0.01% | 833,455 | $11,918,407 | $290,376 | -$11,628,031 | -97.56% | |
| Candriam S.C.A. | 0.05% | 787,769 | $11,254,258 | $274,459 | -$10,979,799 | -97.56% | |
| Artia Global Partners Lp | 2.09% | 767,098 | $10,969,501 | $267,257 | -$10,702,244 | -97.56% | |
| Blue Owl Capital Holdings Lp | 1.66% | 762,594 | $10,905,094 | $265,688 | -$10,639,406 | -97.56% | |
| Northern Trust Corp | 0.00% | 720,917 | $10,309,113 | $251,167 | -$10,057,946 | -97.56% | |
| Patient Square Capital Lp | 1.59% | 720,000 | $10,296,000 | $250,848 | -$10,045,152 | -97.56% | |
| Charles Schwab Investment Management Inc | 0.00% | 647,613 | $9,260,866 | $225,628 | -$9,035,238 | -97.56% | |
| Sio Capital Management, Llc | 1.53% | 623,130 | $8,910,759 | $217,098 | -$8,693,661 | -97.56% | |
| Vanguard Fiduciary Trust Co | 0.00% | 559,216 | $7,996,789 | $194,831 | -$7,801,958 | -97.56% | |
| Alyeska Investment Group, L.P. | 0.02% | 509,403 | $7,284,463 | $177,476 | -$7,106,987 | -97.56% | |
| Millennium Management Llc | 0.00% | 500,093 | $7,151,330 | $174,232 | -$6,977,098 | -97.56% | |
| Goldman Sachs Group Inc | 0.00% | 465,087 | $6,650,744 | $162,036 | -$6,488,708 | -97.56% | |
| Ghisallo Capital Management Llc | 0.10% | 350,000 | $5,005,000 | $121,940 | -$4,883,060 | -97.56% | |
| Stempoint Capital Lp | 0.84% | 338,471 | $4,840,135 | $117,923 | -$4,722,212 | -97.56% | |
| Morgan Stanley | 0.00% | 336,730 | $4,815,240 | $117,317 | -$4,697,923 | -97.56% | |
| E Fund Management Co., Ltd. | 0.11% | 330,774 | $4,730,068 | $115,242 | -$4,614,826 | -97.56% | |
| Jump Financial, Llc | 0.04% | 320,757 | $4,586,825 | $111,752 | -$4,475,073 | -97.56% | |
| Bleichroeder Lp | 0.81% | 316,515 | $4,526,165 | $110,274 | -$4,415,891 | -97.56% | |
| Woodline Partners Lp | 0.01% | 300,463 | $4,296,621 | $104,681 | -$4,191,940 | -97.56% | |
| Eversept Partners, Lp | 0.23% | 297,735 | $4,257,610 | $103,731 | -$4,153,879 | -97.56% | |
| Rock Springs Capital Management Lp | 0.19% | 268,519 | $3,839,822 | $93,552 | -$3,746,270 | -97.56% | |
| Citigroup Inc | 0.00% | 266,910 | $3,816,813 | $92,991 | -$3,723,822 | -97.56% | |
| Bank Of New York Mellon Corp | 0.00% | 250,783 | $3,586,192 | $87,373 | -$3,498,819 | -97.56% | |
| Myda Advisors Llc | 0.87% | 250,000 | $3,575,000 | $87,100 | -$3,487,900 | -97.56% | |
| Ubs Group Ag | 0.00% | 241,363 | $3,451,491 | $84,091 | -$3,367,400 | -97.56% | |
| Bnp Paribas Asset Management Holding S.A. | 0.00% | 234,809 | $3,357,768 | $81,807 | -$3,275,961 | -97.56% |
Frequently asked questions about EYPT
Who are the largest institutional holders of EYPT?
The largest institutional holders of EYPT reported in the latest SEC Form 13F filings include Suvretta Capital Management, Llc, Blackrock, Inc., Cormorant Asset Management, Lp, Federated Hermes, Inc., and Adage Capital Partners Gp, L.L.C.. InsiderSet ranks institutional holders by their latest reported EYPT position.
What is EYPT institutional ownership?
This page tracks EYPT positions reported by institutional investment managers through SEC Form 13F. EYEPOINT PHARMACEUTICALS INC (EYPT) institutional ownership on InsiderSet reflects disclosed 13F holdings among the managers we analyze, not every shareholder of the stock.
How many institutions own EYPT?
InsiderSet currently tracks 177 institutional managers reporting EYPT holdings in the latest available 13F data. This count reflects institutions included in the SEC Form 13F filings analyzed by InsiderSet and should not be interpreted as the total number of EYPT shareholders.
How much EYPT stock do institutions own?
Institutional investment managers disclosed approximately $1.23B in EYPT holdings for Q2 2026. This figure is reported 13F value as of the filing period, not necessarily today's market value.
When was EYPT institutional ownership last updated?
The latest EYPT institutional ownership data on InsiderSet is based on SEC Form 13F filings for the quarter ended June 30, 2026. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time institutional holdings.
Are institutional EYPT holdings real-time?
No. Form 13F data is not real-time. It represents positions reported by institutional investment managers as of the end of the reporting quarter. An institution may have changed its EYPT position after the reporting date.
Are institutions buying or selling EYPT?
Institutional buying and selling can be analyzed by comparing EYPT positions across consecutive 13F reporting periods. InsiderSet's EYPT Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View EYPT ownership changes.
How has EYPT institutional ownership changed over time?
InsiderSet tracks EYPT institutional holdings across multiple 13F reporting periods, allowing investors to compare institutional holder counts, reported value, and reported shares over time.